Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2024

Open Access 01-12-2024 | Coronary Heart Disease | Research

Predictive model and risk analysis for coronary heart disease in people living with HIV using machine learning

Authors: Zengjing Liu, Zhihao Meng, Di Wei, Yuan Qin, Yu Lv, Luman Xie, Hong Qiu, Bo Xie, Lanxiang Li, Xihua Wei, Die Zhang, Boying Liang, Wen Li, Shanfang Qin, Tengyue Yan, Qiuxia Meng, Huilin Wei, Guiyang Jiang, Lingsong Su, Nili Jiang, Kai Zhang, Jiannan Lv, Yanling Hu

Published in: BMC Medical Informatics and Decision Making | Issue 1/2024

Login to get access

Abstract

Objective

This study aimed to construct a coronary heart disease (CHD) risk-prediction model in people living with human immunodeficiency virus (PLHIV) with the help of machine learning (ML) per electronic medical records (EMRs).

Methods

Sixty-one medical characteristics (including demography information, laboratory measurements, and complicating disease) readily available from EMRs were retained for clinical analysis. These characteristics further aided the development of prediction models by using seven ML algorithms [light gradient-boosting machine (LightGBM), support vector machine (SVM), eXtreme gradient boosting (XGBoost), adaptive boosting (AdaBoost), decision tree, multilayer perceptron (MLP), and logistic regression]. The performance of this model was assessed using the area under the receiver operating characteristic curve (AUC). Shapley additive explanation (SHAP) was further applied to interpret the findings of the best-performing model.

Results

The LightGBM model exhibited the highest AUC (0.849; 95% CI, 0.814–0.883). Additionally, the SHAP plot per the LightGBM depicted that age, heart failure, hypertension, glucose, serum creatinine, indirect bilirubin, serum uric acid, and amylase can help identify PLHIV who were at a high or low risk of developing CHD.

Conclusion

This study developed a CHD risk prediction model for PLHIV utilizing ML techniques and EMR data. The LightGBM model exhibited improved comprehensive performance and thus had higher reliability in assessing the risk predictors of CHD. Hence, it can potentially facilitate the development of clinical management techniques for PLHIV care in the era of EMRs.
Literature
2.
go back to reference Singh V, Mendirichaga R, Savani GT, Rodriguez AP, Dabas N, Munagala A, Alfonso CE, Cohen MG, Elmariah S, Palacios IF. Coronary revascularization for acute myocardial infarction in the HIV population. J Interv Cardiol. 2017;30(5):405–14.PubMedCrossRef Singh V, Mendirichaga R, Savani GT, Rodriguez AP, Dabas N, Munagala A, Alfonso CE, Cohen MG, Elmariah S, Palacios IF. Coronary revascularization for acute myocardial infarction in the HIV population. J Interv Cardiol. 2017;30(5):405–14.PubMedCrossRef
3.
go back to reference Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, et al. PACS-HIV (prognosis of Acute Coronary Syndrome in HIV‐Infected patients) investigators †. HIV infection and long-term residual Cardiovascular Risk after Acute Coronary Syndrome. J Am Heart Assoc. 2020;9(17):e017578.PubMedPubMedCentralCrossRef Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, et al. PACS-HIV (prognosis of Acute Coronary Syndrome in HIV‐Infected patients) investigators †. HIV infection and long-term residual Cardiovascular Risk after Acute Coronary Syndrome. J Am Heart Assoc. 2020;9(17):e017578.PubMedPubMedCentralCrossRef
5.
go back to reference Okello S, Amir A, Bloomfield GS, Kentoffio K, Lugobe HM, Reynolds Z, Magodoro IM, North CM, Okello E, Peck R, Siedner MJ. Prevention of cardiovascular disease among people living with HIV in sub-saharan Africa. Prog Cardiovasc Dis. 2020;63(2):149–59.PubMedPubMedCentralCrossRef Okello S, Amir A, Bloomfield GS, Kentoffio K, Lugobe HM, Reynolds Z, Magodoro IM, North CM, Okello E, Peck R, Siedner MJ. Prevention of cardiovascular disease among people living with HIV in sub-saharan Africa. Prog Cardiovasc Dis. 2020;63(2):149–59.PubMedPubMedCentralCrossRef
6.
go back to reference Manga P, McCutcheon K, Tsabedze N, Vachiat A, Zachariah D. HIV and nonischemic heart disease. J Am Coll Cardiol. 2017;69(1):83–91.PubMedCrossRef Manga P, McCutcheon K, Tsabedze N, Vachiat A, Zachariah D. HIV and nonischemic heart disease. J Am Coll Cardiol. 2017;69(1):83–91.PubMedCrossRef
7.
go back to reference Yu J, Liu X, Zhu Z, Yang Z, He J, Zhang L, Lu H. Prediction models for cardiovascular disease risk among people living with HIV: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1138234.PubMedPubMedCentralCrossRef Yu J, Liu X, Zhu Z, Yang Z, He J, Zhang L, Lu H. Prediction models for cardiovascular disease risk among people living with HIV: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1138234.PubMedPubMedCentralCrossRef
8.
go back to reference Vachiat A, McCutcheon K, Tsabedze N, Zachariah D, Manga P. HIV and ischemic heart disease. J Am Coll Cardiol. 2017;69(1):73–82.PubMedCrossRef Vachiat A, McCutcheon K, Tsabedze N, Zachariah D, Manga P. HIV and ischemic heart disease. J Am Coll Cardiol. 2017;69(1):73–82.PubMedCrossRef
9.
go back to reference Demir OM, Candilio L, Fuster D, et al. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol. 2018;265:195–203.PubMedCrossRef Demir OM, Candilio L, Fuster D, et al. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol. 2018;265:195–203.PubMedCrossRef
10.
go back to reference Sinha A, Feinstein MJ. Coronary artery disease manifestations in HIV: what, how, and why. Can J Cardiol. 2019;35(3):270–9.PubMedCrossRef Sinha A, Feinstein MJ. Coronary artery disease manifestations in HIV: what, how, and why. Can J Cardiol. 2019;35(3):270–9.PubMedCrossRef
11.
go back to reference Senoner T, Barbieri F, Adukauskaite A, Sarcletti M, Plank F, Beyer C, Dichtl W, Feuchtner GM. Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography-angiography. AIDS. 2019;33(12):1853–62.PubMedCrossRef Senoner T, Barbieri F, Adukauskaite A, Sarcletti M, Plank F, Beyer C, Dichtl W, Feuchtner GM. Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography-angiography. AIDS. 2019;33(12):1853–62.PubMedCrossRef
12.
go back to reference Boccara F, Kumar PN, Caramelli B, Calmy A, López JAG, Bray S, Cyrille M, Rosenson RS. Beijerinck investigators. Evolocumab in HIV-Infected patients with dyslipidemia: primary results of the Randomized, double-blind BEIJERINCK study. J Am Coll Cardiol. 2020;75(20):2570–84.PubMedCrossRef Boccara F, Kumar PN, Caramelli B, Calmy A, López JAG, Bray S, Cyrille M, Rosenson RS. Beijerinck investigators. Evolocumab in HIV-Infected patients with dyslipidemia: primary results of the Randomized, double-blind BEIJERINCK study. J Am Coll Cardiol. 2020;75(20):2570–84.PubMedCrossRef
13.
go back to reference Hatleberg CI, Ryom L, Sabin C. Cardiovascular risks associated with protease inhibitors for the treatment of HIV. Expert Opin Drug Saf. 2021;20(11):1351–66.PubMedCrossRef Hatleberg CI, Ryom L, Sabin C. Cardiovascular risks associated with protease inhibitors for the treatment of HIV. Expert Opin Drug Saf. 2021;20(11):1351–66.PubMedCrossRef
14.
go back to reference Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–12.PubMedCrossRef Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–12.PubMedCrossRef
15.
go back to reference Perkins MV, Joseph SB, Dittmer DP, Mackman N. Cardiovascular disease and thrombosis in HIV infection. Arterioscler Thromb Vasc Biol. 2023;43(2):175–91.PubMedCrossRef Perkins MV, Joseph SB, Dittmer DP, Mackman N. Cardiovascular disease and thrombosis in HIV infection. Arterioscler Thromb Vasc Biol. 2023;43(2):175–91.PubMedCrossRef
16.
go back to reference Tong Y, Li J, Qin Z, Li Y, Cai W. Analysis of clinical features of coronary heart disease patients with human immunodeficiency virus positive. Chin J Cardiovasc Med. 2021;26(1):5. Tong Y, Li J, Qin Z, Li Y, Cai W. Analysis of clinical features of coronary heart disease patients with human immunodeficiency virus positive. Chin J Cardiovasc Med. 2021;26(1):5.
17.
go back to reference Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard PM, Costagliola D, Cohen A. Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) investigators. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32(1):41–50.PubMedCrossRef Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard PM, Costagliola D, Cohen A. Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) investigators. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32(1):41–50.PubMedCrossRef
18.
go back to reference Godijk NG, Vos AG, Jongen VW, Moraba R, Tempelman H, Grobbee DE, Coutinho RA, Devillé W, Klipstein-Grobusch K. Heart Rate Variability, HIV and the risk of Cardiovascular diseases in Rural South Africa. Glob Heart. 2020;15(1):17.PubMedPubMedCentralCrossRef Godijk NG, Vos AG, Jongen VW, Moraba R, Tempelman H, Grobbee DE, Coutinho RA, Devillé W, Klipstein-Grobusch K. Heart Rate Variability, HIV and the risk of Cardiovascular diseases in Rural South Africa. Glob Heart. 2020;15(1):17.PubMedPubMedCentralCrossRef
19.
go back to reference Moran CA, Southmayd G, Devireddy CM, Quyyumi AA, Ofotokun I, Liberman HA, Jaber W, Sheth AN. Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome. AIDS. 2020;34(1):81–90.PubMedCrossRef Moran CA, Southmayd G, Devireddy CM, Quyyumi AA, Ofotokun I, Liberman HA, Jaber W, Sheth AN. Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome. AIDS. 2020;34(1):81–90.PubMedCrossRef
20.
go back to reference Paisible AL, Chang CC, So-Armah KA, Butt AA, Leaf DA, Budoff M, Rimland D, Bedimo R, Goetz MB, Rodriguez-Barradas MC, Crane HM, Gibert CL, Brown ST, Tindle HA, Warner AL, Alcorn C, Skanderson M, Justice AC, Freiberg MS. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J Acquir Immune Defic Syndr. 2015;68(2):209–16.PubMedCrossRef Paisible AL, Chang CC, So-Armah KA, Butt AA, Leaf DA, Budoff M, Rimland D, Bedimo R, Goetz MB, Rodriguez-Barradas MC, Crane HM, Gibert CL, Brown ST, Tindle HA, Warner AL, Alcorn C, Skanderson M, Justice AC, Freiberg MS. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J Acquir Immune Defic Syndr. 2015;68(2):209–16.PubMedCrossRef
21.
go back to reference Li W, Song Y, Chen K, Ying J, Zheng Z, Qiao S, et al. Predictive model and risk analysis for diabetic retinopathy using machine learning: a retrospective cohort study in China. BMJ Open. 2021;11(11):e050989.PubMedPubMedCentralCrossRef Li W, Song Y, Chen K, Ying J, Zheng Z, Qiao S, et al. Predictive model and risk analysis for diabetic retinopathy using machine learning: a retrospective cohort study in China. BMJ Open. 2021;11(11):e050989.PubMedPubMedCentralCrossRef
22.
go back to reference Kukar M, Kononenko I, Groselj C, Kralj K, Fettich J. Analysing and improving the diagnosis of ischaemic heart disease with machine learning. Artif Intell Med. 1999;16(1):25–50.PubMedCrossRef Kukar M, Kononenko I, Groselj C, Kralj K, Fettich J. Analysing and improving the diagnosis of ischaemic heart disease with machine learning. Artif Intell Med. 1999;16(1):25–50.PubMedCrossRef
23.
go back to reference Gautam N, Mueller J, Alqaisi O, Gandhi T, Malkawi A, Tarun T, Alturkmani HJ, Zulqarnain MA, Pontone G, Al’Aref SJ. Machine Learning in Cardiovascular Risk Prediction and Precision Preventive approaches. Curr Atheroscler Rep. 2023;25(12):1069–81.PubMedCrossRef Gautam N, Mueller J, Alqaisi O, Gandhi T, Malkawi A, Tarun T, Alturkmani HJ, Zulqarnain MA, Pontone G, Al’Aref SJ. Machine Learning in Cardiovascular Risk Prediction and Precision Preventive approaches. Curr Atheroscler Rep. 2023;25(12):1069–81.PubMedCrossRef
24.
go back to reference Helman SM, Herrup EA, Christopher AB, Al-Zaiti SS. The role of machine learning applications in diagnosing and assessing critical and non-critical CHD: a scoping review. Cardiol Young. 2021;31(11):1770–80.PubMedPubMedCentralCrossRef Helman SM, Herrup EA, Christopher AB, Al-Zaiti SS. The role of machine learning applications in diagnosing and assessing critical and non-critical CHD: a scoping review. Cardiol Young. 2021;31(11):1770–80.PubMedPubMedCentralCrossRef
25.
go back to reference Wang K, Tian J, Zheng C, Yang H, Ren J, Liu Y, Han Q, Zhang Y. Interpretable prediction of 3-year all-cause mortality in patients with heart failure caused by coronary heart disease based on machine learning and SHAP. Comput Biol Med. 2021;137:104813.PubMedCrossRef Wang K, Tian J, Zheng C, Yang H, Ren J, Liu Y, Han Q, Zhang Y. Interpretable prediction of 3-year all-cause mortality in patients with heart failure caused by coronary heart disease based on machine learning and SHAP. Comput Biol Med. 2021;137:104813.PubMedCrossRef
26.
go back to reference Ye Z, An S, Gao Y, Xie E, Zhao X, Guo Z, Li Y, Shen N, Ren J, Zheng J. The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models. Eur J Med Res. 2023;28(1):33.PubMedPubMedCentralCrossRef Ye Z, An S, Gao Y, Xie E, Zhao X, Guo Z, Li Y, Shen N, Ren J, Zheng J. The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models. Eur J Med Res. 2023;28(1):33.PubMedPubMedCentralCrossRef
28.
go back to reference Bader-El-Den M, Teitei E, Perry T. Biased Random Forest for dealing with the Class Imbalance Problem. IEEE Trans Neural Netw Learn Syst. 2019;30(7):2163–72.PubMedCrossRef Bader-El-Den M, Teitei E, Perry T. Biased Random Forest for dealing with the Class Imbalance Problem. IEEE Trans Neural Netw Learn Syst. 2019;30(7):2163–72.PubMedCrossRef
29.
go back to reference Yang PT, Wu WS, Wu CC, Shih YN, Hsieh CH, Hsu JL. Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning. Open Med (Wars). 2021;16(1):754–68.PubMedCrossRef Yang PT, Wu WS, Wu CC, Shih YN, Hsieh CH, Hsu JL. Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning. Open Med (Wars). 2021;16(1):754–68.PubMedCrossRef
30.
go back to reference Ke G, Meng Q, Finley T, Wang T, Chen W, Ma W, et al. Lightgbm: a highly efcient gradient boosting decision tree. Adv Neural Inf Process Syst. 2017;30:3146–54. Ke G, Meng Q, Finley T, Wang T, Chen W, Ma W, et al. Lightgbm: a highly efcient gradient boosting decision tree. Adv Neural Inf Process Syst. 2017;30:3146–54.
31.
go back to reference Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Statist. 2001;29(5):1189–232.CrossRef Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Statist. 2001;29(5):1189–232.CrossRef
32.
go back to reference Tunç T. A new hybrid method logistic regression and feedforward neural network for lung cancer data. Math Probl Eng. 2012. Tunç T. A new hybrid method logistic regression and feedforward neural network for lung cancer data. Math Probl Eng. 2012.
33.
go back to reference Suykens J, Vandewalle J. Least squares support vector machine classifiers. Neural Process Lett. 1999;9:293–300.CrossRef Suykens J, Vandewalle J. Least squares support vector machine classifiers. Neural Process Lett. 1999;9:293–300.CrossRef
34.
go back to reference Geurts P, Irrthum A, Wehenkel L. Supervised learning with decision tree-based methods in computational and systems biology. Mol Biosyst. 2009;5(12):1593–605.PubMedCrossRef Geurts P, Irrthum A, Wehenkel L. Supervised learning with decision tree-based methods in computational and systems biology. Mol Biosyst. 2009;5(12):1593–605.PubMedCrossRef
35.
go back to reference Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Advances in neural information Processing sys-tems. 2017:4765–74. Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Advances in neural information Processing sys-tems. 2017:4765–74.
36.
go back to reference Friis-Møller N, Thiebaut R, Reiss P, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabilitation. 2010;17(5):491–501.CrossRef Friis-Møller N, Thiebaut R, Reiss P, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabilitation. 2010;17(5):491–501.CrossRef
37.
go back to reference Thompson-Paul AM, Lichtenstein KA, Armon C, et al. Cardiovascular disease risk prediction in the HIV outpatient study. Clin Infect Dis. 2016;63(11):1508–16.PubMedCrossRef Thompson-Paul AM, Lichtenstein KA, Armon C, et al. Cardiovascular disease risk prediction in the HIV outpatient study. Clin Infect Dis. 2016;63(11):1508–16.PubMedCrossRef
38.
go back to reference Van Zoest RA, Law M, Sabin CA et al. Predictive performance of cardiovascular disease risk prediction algorithms in people living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. Van Zoest RA, Law M, Sabin CA et al. Predictive performance of cardiovascular disease risk prediction algorithms in people living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes.
39.
go back to reference Friis-Møller N, Ryom L, Smith C, et al. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the Data-collection on adverse effects of Anti-HIV drugs (D: A: D) study. Eur J Prev Cardiol. 2016;23(2):214–23.PubMedCrossRef Friis-Møller N, Ryom L, Smith C, et al. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the Data-collection on adverse effects of Anti-HIV drugs (D: A: D) study. Eur J Prev Cardiol. 2016;23(2):214–23.PubMedCrossRef
40.
go back to reference Feinstein MJ, Nance RM, Drozd DR, et al. Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the Centers for AIDS Research Network of Integrated Clinical Systems. JAMA Cardiol. 2017;2(2):155–62.PubMedPubMedCentralCrossRef Feinstein MJ, Nance RM, Drozd DR, et al. Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the Centers for AIDS Research Network of Integrated Clinical Systems. JAMA Cardiol. 2017;2(2):155–62.PubMedPubMedCentralCrossRef
41.
go back to reference Yu J, Liu X, Zhu Z, et al. Prediction models for cardiovascular disease risk among people living with HIV: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1138234.PubMedPubMedCentralCrossRef Yu J, Liu X, Zhu Z, et al. Prediction models for cardiovascular disease risk among people living with HIV: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1138234.PubMedPubMedCentralCrossRef
42.
go back to reference Rufo DD, Debelee TG, Ibenthal A, Negera WG. Diagnosis of diabetes Mellitus using gradient boosting machine (LightGBM). Diagnostics (Basel). 2021;11(9):1714.PubMedCrossRef Rufo DD, Debelee TG, Ibenthal A, Negera WG. Diagnosis of diabetes Mellitus using gradient boosting machine (LightGBM). Diagnostics (Basel). 2021;11(9):1714.PubMedCrossRef
43.
go back to reference Oh JY, Greene K, He H, Schafer S, Hedberg K. Population-based study of risk factors for coronary heart disease among HIV-infected persons. Open AIDS J. 2012;6:177–80.PubMedPubMedCentralCrossRef Oh JY, Greene K, He H, Schafer S, Hedberg K. Population-based study of risk factors for coronary heart disease among HIV-infected persons. Open AIDS J. 2012;6:177–80.PubMedPubMedCentralCrossRef
44.
go back to reference Chan EY, Qian WJ, Diamond DL, Liu T, Gritsenko MA, Monroe ME, et al. Quantitative analysis of human immunodeficiency virus type 1-infected CD4 + cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol. 2007;81(14):7571–83.PubMedPubMedCentralCrossRef Chan EY, Qian WJ, Diamond DL, Liu T, Gritsenko MA, Monroe ME, et al. Quantitative analysis of human immunodeficiency virus type 1-infected CD4 + cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol. 2007;81(14):7571–83.PubMedPubMedCentralCrossRef
45.
go back to reference Aragonès G, Alonso-Villaverde C, Oliveras-Ferraros C, Beltrán-Debón R, Rull A, Rodríguez-Sanabria F, et al. Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection. BMC Gastroenterol. 2010;10:92.PubMedPubMedCentralCrossRef Aragonès G, Alonso-Villaverde C, Oliveras-Ferraros C, Beltrán-Debón R, Rull A, Rodríguez-Sanabria F, et al. Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection. BMC Gastroenterol. 2010;10:92.PubMedPubMedCentralCrossRef
46.
go back to reference Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77.PubMedCrossRef Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77.PubMedCrossRef
47.
go back to reference Adeva-Andany MM, Ameneiros-Rodríguez E, Fernández-Fernández C, Domínguez-Montero A, Funcasta-Calderón R. Insulin resistance is associated with subclinical vascular disease in humans. World J Diabetes. 2019;10(2):63–77.PubMedPubMedCentralCrossRef Adeva-Andany MM, Ameneiros-Rodríguez E, Fernández-Fernández C, Domínguez-Montero A, Funcasta-Calderón R. Insulin resistance is associated with subclinical vascular disease in humans. World J Diabetes. 2019;10(2):63–77.PubMedPubMedCentralCrossRef
48.
go back to reference Siddiqui M, Hannon L, Wang Z, Blair J, Oparil S, Heath SL, et al. Hypertension and Cardiovascular Disease Risk among individuals with Versus without HIV. Hypertension. 2023;80(4):852–60.PubMed Siddiqui M, Hannon L, Wang Z, Blair J, Oparil S, Heath SL, et al. Hypertension and Cardiovascular Disease Risk among individuals with Versus without HIV. Hypertension. 2023;80(4):852–60.PubMed
49.
go back to reference Yen YF, Ko MC, Yen MY, Hu BS, Wang TH, Chuang PH, et al. Human immunodeficiency Virus increases the risk of Incident Heart failure. J Acquir Immune Defic Syndr. 2019;80(3):255–63.PubMedCrossRef Yen YF, Ko MC, Yen MY, Hu BS, Wang TH, Chuang PH, et al. Human immunodeficiency Virus increases the risk of Incident Heart failure. J Acquir Immune Defic Syndr. 2019;80(3):255–63.PubMedCrossRef
50.
go back to reference AS G, Reynolds K, Avula HR, Towner WJ, Hechter RC, Horberg MA, et al. Human immunodeficiency virus infection and variation in heart failure risk by Age, Sex, and ethnicity: the HIV HEART Study. Mayo Clin Proc. 2022;97(3):465–79.CrossRef AS G, Reynolds K, Avula HR, Towner WJ, Hechter RC, Horberg MA, et al. Human immunodeficiency virus infection and variation in heart failure risk by Age, Sex, and ethnicity: the HIV HEART Study. Mayo Clin Proc. 2022;97(3):465–79.CrossRef
51.
go back to reference Lam JO, Leyden WA, Leong TK, Horberg MA, Reynolds K, Ambrosy AP, et al. Variation in heart failure risk by HIV Severity and Sex in People with HIV infection. J Acquir Immune Defic Syndr. 2022;91(2):175–81.PubMedPubMedCentralCrossRef Lam JO, Leyden WA, Leong TK, Horberg MA, Reynolds K, Ambrosy AP, et al. Variation in heart failure risk by HIV Severity and Sex in People with HIV infection. J Acquir Immune Defic Syndr. 2022;91(2):175–81.PubMedPubMedCentralCrossRef
52.
go back to reference Bagheri B, Radmard N, Faghani-Makrani A, Rasouli M. Serum creatinine and occurrence and severity of coronary artery disease. Med Arch. 2019;73(3):154–6.PubMedPubMedCentralCrossRef Bagheri B, Radmard N, Faghani-Makrani A, Rasouli M. Serum creatinine and occurrence and severity of coronary artery disease. Med Arch. 2019;73(3):154–6.PubMedPubMedCentralCrossRef
53.
go back to reference Olusola BA, Kabelitz D, Olaleye DO, Odaibo GN. Early HIV infection is associated with reduced proportions of gamma delta T subsets as well as high creatinine and urea levels. Scand J Immunol. 2020;91(5):e12868.PubMedPubMedCentralCrossRef Olusola BA, Kabelitz D, Olaleye DO, Odaibo GN. Early HIV infection is associated with reduced proportions of gamma delta T subsets as well as high creatinine and urea levels. Scand J Immunol. 2020;91(5):e12868.PubMedPubMedCentralCrossRef
54.
go back to reference Marconi VC, Duncan MS, So-Armah K, Re VL 3rd, Lim JK, Butt AA, et al. Bilirubin is inversely Associated with Cardiovascular Disease among HIV-Positive and HIV-Negative individuals in VACS (Veterans Aging Cohort Study). J Am Heart Assoc. 2018;7(10):e007792.PubMedPubMedCentralCrossRef Marconi VC, Duncan MS, So-Armah K, Re VL 3rd, Lim JK, Butt AA, et al. Bilirubin is inversely Associated with Cardiovascular Disease among HIV-Positive and HIV-Negative individuals in VACS (Veterans Aging Cohort Study). J Am Heart Assoc. 2018;7(10):e007792.PubMedPubMedCentralCrossRef
55.
go back to reference Moore JR, Schneider SM. Acute human immunodeficiency virus (HIV) infection presenting with fever, elevated amylase/lipase, and hematologic abnormalities. J Emerg Med. 2013;44(5):e341–4.PubMedCrossRef Moore JR, Schneider SM. Acute human immunodeficiency virus (HIV) infection presenting with fever, elevated amylase/lipase, and hematologic abnormalities. J Emerg Med. 2013;44(5):e341–4.PubMedCrossRef
56.
go back to reference Jin Y, Yang T, Xia T, Shen Z, Ma T. Association between serum amylase levels and CD4 cell counts in newly diagnosed people living with HIV: a case-control study. Med (Baltim). 2023;102(2):e32638.CrossRef Jin Y, Yang T, Xia T, Shen Z, Ma T. Association between serum amylase levels and CD4 cell counts in newly diagnosed people living with HIV: a case-control study. Med (Baltim). 2023;102(2):e32638.CrossRef
57.
go back to reference Park SY, Kim MJ, Park I, Kim HY, Lee M, Park YS, et al. Predisposing factors and neurologic outcomes of patients with elevated serum amylase and/or lipase after out-of-hospital cardiac arrest: a retrospective cohort study. J Clin Med. 2022;11(5):1426.PubMedPubMedCentralCrossRef Park SY, Kim MJ, Park I, Kim HY, Lee M, Park YS, et al. Predisposing factors and neurologic outcomes of patients with elevated serum amylase and/or lipase after out-of-hospital cardiac arrest: a retrospective cohort study. J Clin Med. 2022;11(5):1426.PubMedPubMedCentralCrossRef
58.
go back to reference Nikolic S, Dugic A, Steiner C, Tsolakis AV, Haugen Löfman IM, Löhr JM, et al. Chronic pancreatitis and the heart disease: still terra incognita? World J Gastroenterol. 2019;25(44):6561–70.PubMedPubMedCentralCrossRef Nikolic S, Dugic A, Steiner C, Tsolakis AV, Haugen Löfman IM, Löhr JM, et al. Chronic pancreatitis and the heart disease: still terra incognita? World J Gastroenterol. 2019;25(44):6561–70.PubMedPubMedCentralCrossRef
59.
go back to reference Desai A, Chandan S, Ramai D, Kaul V, Kochhar GS. Chronic pancreatitis and risk of atherosclerotic Cardiovascular Disease: a US Cohort Propensity-Matched Study. Pancreas. 2023;52(1):e21–8.PubMedCrossRef Desai A, Chandan S, Ramai D, Kaul V, Kochhar GS. Chronic pancreatitis and risk of atherosclerotic Cardiovascular Disease: a US Cohort Propensity-Matched Study. Pancreas. 2023;52(1):e21–8.PubMedCrossRef
60.
go back to reference Olaniyi JA, Arinola OG. Essential trace elements and antioxidant status in relation to severity of HIV in Nigerian patients. Med Princ Pract. 2007;16(6):420–5.PubMedCrossRef Olaniyi JA, Arinola OG. Essential trace elements and antioxidant status in relation to severity of HIV in Nigerian patients. Med Princ Pract. 2007;16(6):420–5.PubMedCrossRef
61.
go back to reference Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–7.PubMedCrossRef Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–7.PubMedCrossRef
62.
go back to reference Nicholson P, Saunsbury E, D’Angelo S, Churchill D, Walker-Bone K. Prevalence of and risk factors for gout in HIV-positive adults: a case-control study. Int J STD AIDS. 2019;30(3):249–55.PubMedCrossRef Nicholson P, Saunsbury E, D’Angelo S, Churchill D, Walker-Bone K. Prevalence of and risk factors for gout in HIV-positive adults: a case-control study. Int J STD AIDS. 2019;30(3):249–55.PubMedCrossRef
Metadata
Title
Predictive model and risk analysis for coronary heart disease in people living with HIV using machine learning
Authors
Zengjing Liu
Zhihao Meng
Di Wei
Yuan Qin
Yu Lv
Luman Xie
Hong Qiu
Bo Xie
Lanxiang Li
Xihua Wei
Die Zhang
Boying Liang
Wen Li
Shanfang Qin
Tengyue Yan
Qiuxia Meng
Huilin Wei
Guiyang Jiang
Lingsong Su
Nili Jiang
Kai Zhang
Jiannan Lv
Yanling Hu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2024
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-024-02511-5

Other articles of this Issue 1/2024

BMC Medical Informatics and Decision Making 1/2024 Go to the issue